Page 11234..10..»


Category Archives: Hypogonadism

Alcohol Consumption Linked to Lower Bone Formation Markers in Patients With HIV – Infectious Disease Advisor


Posted: March 23, 2020 at 11:44 am

Greater alcohol consumption is associated with lower serum bone formation markers in patients living with HIV (PLWHIV) with substance use disorder, according to study results published in Alcoholism: Clinical and Experimental Research. Previous studies have established that low bone mass is common and fracture risk is increased for PLWHIV. Several factors may contribute to the low bone density, including the effect of HIV itself, low body mass index, hypogonadism, liver disease, and smoking and alcohol consumption. Continue reading

Posted in Hypogonadism | Comments Off on Alcohol Consumption Linked to Lower Bone Formation Markers in Patients With HIV – Infectious Disease Advisor

Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and Mexico – Yahoo Finance


Posted: March 20, 2020 at 6:44 am

Company Expects to Seek Regulatory Clearance Under Health Canada and COFEPRIS Expedited Clearance Procedures ENGLEWOOD, CO / ACCESSWIRE / March 19, 2020 / Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it extended its distribution right to commercialize the clinically validated and commercially used coronavirus 2019 (COVID-19) IgG/IgM Rapid Test. The test has been licensed from L.B Continue reading

Posted in Hypogonadism | Comments Off on Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and Mexico – Yahoo Finance

FDA: Thousands of Deaths Associated With Drugs Given to ‘Trans’ Children – Catholic Citizens of Illinois


Posted: March 20, 2020 at 6:44 am

Fatal blood clots, suicidal behavior, lowered IQs, brittle bones andsterility are just a few of the potential side effects of puberty blockersthat the transgender industry doesnt want talked about. By Celeste McGovern, September 18, 2019 Thousands of children attending affirmative gender health clinicsglobally, including in the United States and the United Kingdom, are beinggiven powerful puberty-blocking drugs with a litany of serious side effects including death according to Food and Drug Administration data. Continue reading

Posted in Hypogonadism | Comments Off on FDA: Thousands of Deaths Associated With Drugs Given to ‘Trans’ Children – Catholic Citizens of Illinois

Aytu BioScience Announces Acceleration of U.S. Availability of COVID-19 IgG/IgM Rapid Test Based on Updated FDA Policy – Yahoo Finance


Posted: March 18, 2020 at 6:41 am

Updated FDA Policy Likely Enables Near-Term Availability of COVID-19 Test in the U.S. Continue reading

Posted in Hypogonadism | Comments Off on Aytu BioScience Announces Acceleration of U.S. Availability of COVID-19 IgG/IgM Rapid Test Based on Updated FDA Policy – Yahoo Finance

CLARUS THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT THE COMMERCIAL LAUNCH AND AVAILABILITY OF JATENZO (TESTOSTERONE UNDECANOATE) CAPSULES, CIII FOR THE…


Posted: March 16, 2020 at 6:41 pm

Financing to speed commercialization of the only FDA-approved oral treatment of its kind for testosterone deficiency1,2 NORTHBROOK, Ill., March 16, 2020 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a commercial mens health specialty pharmaceutical company, announced today that it has completed a senior debt financing of up to $75M. Continue reading

Posted in Hypogonadism | Comments Off on CLARUS THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT THE COMMERCIAL LAUNCH AND AVAILABILITY OF JATENZO (TESTOSTERONE UNDECANOATE) CAPSULES, CIII FOR THE…

Aytu BioScience’s Coronavirus Rapid Test Featured on NBC and Fox News (VIDEOS): ”Englewood Company Says It Can Get COVID-19 Test Results in 2-10…


Posted: March 16, 2020 at 6:41 pm

ENGLEWOOD, CO / ACCESSWIRE / March 16, 2020 / Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today it was featured on a FOX segment titled: "Englewood company says it can get COVID-19 test results in 2-10 minutes," reported on by affiliated television station in Denver, Colorado, KDVR; and on an NBC segment titled "2-minute COVID-19 test results? Denver-area company wants to deliver that promise," reported on by affiliated television station in Denver, Colorado, KUSA Continue reading

Posted in Hypogonadism | Comments Off on Aytu BioScience’s Coronavirus Rapid Test Featured on NBC and Fox News (VIDEOS): ”Englewood Company Says It Can Get COVID-19 Test Results in 2-10…

Long-term Opioid Use in Men Linked to Hypogonadism – Medscape


Posted: March 15, 2020 at 10:52 pm

NATIONAL HARBOR, Maryland Long-term opioid use in men is linked to a significantly increased risk for hypogonadism, new research suggests. Findings from a retrospective case-control study show that men who used long-acting opioids on a long-term basis had close to a 1.5-fold increased risk of developing the condition. Continue reading

Posted in Hypogonadism | Comments Off on Long-term Opioid Use in Men Linked to Hypogonadism – Medscape

Alcohol Consumption Linked to Lower Bone Formation Markers in Patients With HIV – Endocrinology Advisor


Posted: March 15, 2020 at 10:52 pm

Greater alcohol consumption is associated with lower serum bone formation markers in patients living with HIV (PLWHIV) with substance use disorder, according to study results published in Alcoholism: Clinical and Experimental Research. Previous studies have established that low bone mass is common and fracture risk is increased for PLWHIV. Several factors may contribute to the low bone density, including the effect of HIV itself, low body mass index, hypogonadism, liver disease, and smoking and alcohol consumption Continue reading

Posted in Hypogonadism | Comments Off on Alcohol Consumption Linked to Lower Bone Formation Markers in Patients With HIV – Endocrinology Advisor

Hypogonadism Linked to Higher Long-Term Opioid Doses – MedPage Today


Posted: March 7, 2020 at 3:47 pm

NATIONAL HARBOR, Md. -- Chronic opioid use may have a dose-response relationship with hypogonadism, a retrospective case-control study suggested. For men on long-term opioids, the odds of developing hypogonadism went up 44% for every 100 units in maximum morphine equivalent daily dose (MEDD), reported Yashar Eshraghi, MD, of the University of Queensland Ochsner Clinical School in New Orleans, at the annual meeting of the American Academy of Pain Medicine Continue reading

Posted in Hypogonadism | Comments Off on Hypogonadism Linked to Higher Long-Term Opioid Doses – MedPage Today

‘A Magnet for Cancer’: What We Heard This Week – MedPage Today


Posted: March 7, 2020 at 3:47 pm

"My body just feels like a magnet for cancer." -- Lisa Geller, an immunotherapy super-responder, on life before remission. "That is a really important paradigm shift that could help a lot of people avoid overtreatment of prostate cancer and help a lot of physicians get a lot more confidence about their diagnoses." -- Michael Ahdoot, MD, NCI Urologic Oncology Branch, commenting on a study showing combined biopsy is more accurate than either MRI- or TRUS-guided biopsy. "Nothing any of us is going to do will make more healthcare workers to fight this battle, so they get priority." -- Ken Cuccinelli, currently performing the duties of deputy secretary at the Department of Homeland Security, on how healthcare workers are a "limited resource" on the COVID-19 front. Continue reading

Posted in Hypogonadism | Comments Off on ‘A Magnet for Cancer’: What We Heard This Week – MedPage Today

Page 11234..10..»